Folic acid and human reproduction - Ten important issues for clinicians

Journal of Experimental and Clinical Assisted Reproduction

Volumn 8, Issue , 2011, Pages

  Dunlap, Beth ^a   Shelke, Kantha ^b   Salem, Shala A ^c   Keith, Louis G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Corvus Blue LLC ^*  (United States)

^c Pacific Reproductive Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIET SUPPLEMENTATION; ETHNIC DIFFERENCE; EVIDENCE BASED PRACTICE; FIRST TRIMESTER PREGNANCY; FOLIC ACID DEFICIENCY; HUMAN; MALE FERTILITY; MONITORING; NEURAL TUBE DEFECT; PATIENT COMPLIANCE; RACE DIFFERENCE; RECOMMENDED DRUG DOSE; REPRODUCTION; REVIEW; RISK FACTOR;

EID: 82455203863     PISSN: 17431050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001;(3):CD001056.
2. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999 Nov 11;341(20):1509-1519. (Pubitemid 29526355)
3. Nchs - Health E Stats - Trends in Spina Bifida and Anencephalus in the United States, 1991-2005 [Internet]. [cited 2009 Aug 23] Available from: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/spine-anen.htm
4. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet 2004 Nov 20;364(9448):1885-1895. (Pubitemid 39536093)
5. Budhiraja S, Dahiya P, Ghei M, Gathwala G. Neural-tube defect in dizygotic twins. Ped Surg Intl 2002 Mar 8;18(2):211-212. (Pubitemid 36014890)
6. Shaw GM, Velie EM, Wasserman CR. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am J Public Health 1997 Sep;87(9):1467-1471. (Pubitemid 27415003)
7. Seller MJ, Nevin NC. Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet 1984 Oct 1;21(5):325-330. (Pubitemid 14049036)
8. Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans living on the US-Mexico border: Effects of folic acid and dietary folate. Am J Epidemiol 2000 Dec 1;152(11):1017-1023.
9. Kibar Z, Capra V, Gros P. Toward understanding the genetic basis of neural tube defects. Clinical Genetics 2007;71(4):295-310. (Pubitemid 46680796)
10. Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme SL. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health 1998 Nov;88(11):1674-1680. (Pubitemid 28499149)
11. Yang J, Carmichael SL, Canfield M, Song J, Shaw GM. Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study. Am J Epidemiol 2008 Jan 15;167(2):145-154.
12. Frey L, Hauser WA. Epidemiology of neural tube defects. Epilepsia 2003;44(Suppl):34-13.
13. Bol KA, Collins JS, Kirby RS. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 2006 Mar;117(3):803-813. (Pubitemid 46063223)
14. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999 Nov 11;341(20):1485-1490.
15. Berry RJ, Li Z. Folic acid alone prevents neural tube defects: Evidence from the China study. Epidemiology 2002 Jan;13(1):114-116. (Pubitemid 34031520)
16. Zeisel SH. Importance of methyl donors during reproduction. Am J Clin Nutr 2009 Feb 1;89(2):673S-677.
17. Beaudin AE, Stover PJ. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a mini review. Birth Defects Research Part A: Clin Mol Teratol 2009;85(4):274-284.
18. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992 Dec 24;327(26):1832-1835. (Pubitemid 23003073)
19. Hibbard BM. Defective folate metabolism in pathological conditions of pregnancy. Acta Obstet Gynecol Scand 1967;46(7)(Suppl 7):47-59.
20. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991 Jul 20;338(8760):131-137.
21. Centers for Disease Control. Effectiveness in disease and injury prevention use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. MMWR 1991 Aug 2;40(30):513-516.
22. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects [Internet]. MMWR. 1992. Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/00019479.htm
23. Busby A, Armstrong B, Dolk H, Armstrong N, Haeusler M, Berghold A, et al. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol Sep;20(3):393-402.
24. Koren G, Goh YI, Klieger C. Folic acid: the right dose. Can Fam Physician 2008 Nov;54(11):1545-1547.
25. Wilson RD, Johnson J, Wyatt P, Allen V, Gagnon A, Langlois S, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007 Dec;29(12):1003-1026.
26. Institute of Medicine. National Academies Press; Washington DC: 1998. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin b6, folate, vitamin B12, pantothenic acid, biotin, and choline: a report of the standing committee on the scientific evaluation of dietary reference intakes and its panel of folate, other B vitamins, and choline and subcommittee on upper reference levels of nutrients; p. 55-422.
27. Oakley GP, Weber MB, Bell KN, Colditz P. Scientific evidence supporting folic acid fortification of flour in Australia and New Zealand. Birth Defects Research Part A: Clin Mol Teratol 2004 Nov; 70(11):838-841. (Pubitemid 39602193)
28. Hertrampf E, Cortés F. National food-fortification program with folic acid in Chile. Food Nutr Bull 2008 Jun;29(2 Suppl):S231-237.
29. Mills JL, Von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE, et al. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr 2003 Jun 1;77(6):1474-1477. (Pubitemid 39655282)
30. Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006 Apr 22;367(9519):1352-1361.
31. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997 Dec 6;350(9092):1666-1669. (Pubitemid 28036827)
32. Wald NJ. Folic acid and the prevention of neural-tube defects. N Engl J Med 2004 Jan 8;350(2):101-103. (Pubitemid 38056219)
33. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995 Dec 6;274(21):1698-1702.
34. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001 Dec 15;358(9298):2069-2073. (Pubitemid 34084836)
35. Wyszynski, D. Neural tube defects: From origin to treatment. New York: Oxford University Press; 2006.
36. Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 2003 Mar;14(2):200-205. (Pubitemid 40417107)
37. Centers for Disease Control. Prevention program for reducing risk for neural tube defects - South Carolina, 1992-1994. MMWR 1995 Mar 3;44(08):141-142.
38. Green-Raleigh K, Carter H, Mulinare J, Prue C, Petrini J. Trends in folic Acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995-2005. Matern Child Health J 2006 Sep;10(5 Suppl):S177-182.
39. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998 Feb;30(1):24-29. 46.
40. Bell KN, Oakley GP. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Research Part A: Clin Mol Teratol 2009 Jan;85(1):102-107.
41. López-Camelo JS, Orioli IM, Dutra MDG, Nazer-Herrera J, Rivera N, Ojeda ME, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Gen Part A 2005;135A(2):120-125. (Pubitemid 40769959)
42. Mandatory folic acid fortification in Australia, Fact Sheets 2009. Food Standards Australia New Zealand. 2009. Available from: http://www.foodstandards. gov.au/consumerinformation/fortification/
43. Centers for Disease Control. Folate status in women of childbearing age, by race/ethnicity - United States, 1999-2000, 2001-2002, and 2003-2004. MMWR 2007 Jan 5;55(51):1377-1380.
44. Yang Q, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: Findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 2007 May;85(5):1409-1416. (Pubitemid 46740486)
45. Dowd JB, Aiello AE. Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US? Int J Epidemiol 2008 Oct;37(5):1059-1066.
46. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 2007 Sep;86(3):718-727. (Pubitemid 47435840)
47. 16 Maternal, Infant, and Child Health [Internet]. [cited 2009 Oct 18] Available from: http://www.healthypeople.gov/document/HTML/Volume2/16MICH.htm#- Toc494699666
48. Perlow JH. Comparative use and knowledge of preconceptional folic acid among Spanish- and English-speaking patient populations in Phoenix and Yuma, Arizona. Am J Obstet Gynecol 2001 May; 184(6):1263-1266. (Pubitemid 32434284)
49. Chacko MR, Anding R, Kozinetz CA, Grover JL, Smith PB. Neural tube defects: Knowledge and preconceptional prevention practices in minority young women. Pediatrics 2003 Sep 1;112(3):536-542. (Pubitemid 37082103)
50. Farley T, Rice J, Bodor J, Cohen D, Blumenthal R, Rose D. Measuring the food environment: Shelf space of fruits, vegetables, and snack foods in stores. J Urban Health 2009;86(5):672-682.
51. Morland K, Filomena S. Disparities in the availability of fruits and vegetables between racially segregated urban neighbourhoods. Public Health Nutr 2007 Dec;10(12):1481-1489. (Pubitemid 350146571)
52. Choumenkovitch SF, Selhub J, Wilson PWF, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002 Sep;132(9):2792-2798. (Pubitemid 35013272)
53. Quinlivan EP, Gregory JF. Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 2007 Dec;86(6):1773-1779. (Pubitemid 350232195)
54. Dietrich M, Brown CJP, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 2005 Aug;24(4):266-274. (Pubitemid 43193852)
55. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988 Dec 2;260(21):3141-3145.
56. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989 Nov 24;262(20):2847-2852. (Pubitemid 20002544)
57. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995 May;6(3):219-226.
58. Mills J, Rhoads G, Simpson J, Cunningham G, Conley M, Lassman M, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. N Engl J Med 1989 Aug 17;321(7):430-435.
59. Besser LM, Williams LJ, Cragan JD. Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968-2003. Birth Defects Research Part A: Clin Mol Teratol 2007;79(11):730-736. (Pubitemid 350271819)
60. Busby A, Abramsky L, Dolk H, Armstrong B. Preventing neural tube defects in Europe: Population based study. BMJ 2005 Mar 12;330(7491):574-575. (Pubitemid 40380352)
61. McDonnell R, Johnson Z, Delaney V, Dack P. East Ireland 1980-1994: Epidemiology of neural tube defects. J Epidemiol Community Health 1999 Dec 1;53(12):782-788.
62. Morris JK, Wald NJ. Quantifying the decline in the birth prevalence of neural tube defects in England and Wales. J Med Screening 1999;6(4):182.
63. Mills JL, Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Research Part A: Clin Mol Teratol 2004;70(11):844-845. (Pubitemid 39610502)
64. Stoll C, Alembik Y, Dott B, Roth MP. Impact of prenatal diagnosis on livebirth prevalence of children with congenital anomalies. Annales de Génétique Jul;45(3):115-121.
65. Watkins ML, Edmonds L, McClearn A, Mullins L, Mulinare J, Khoury M. The surveillance of birth defects: the usefulness of the revised US standard birth certificate. Am J Public Health 1996 May 1;86(5):731-734. (Pubitemid 26145490)
66. Mills JL, Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Research Part A: Clin Mol Teratol 2004 Nov;70(11):844-845. (Pubitemid 39610502)
67. Centers for Disease Control. 2004 May 7. Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000; p. 53362-5.
68. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001 Jun 20;285(23):2981-2986. (Pubitemid 32550116)
69. De Wals P, Tairou F, Van Allen MI, Uh S, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007 Jul 12;357(2):135-142. (Pubitemid 47057731)
70. Gucciardi E, Pietrusiak M, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 2002 Aug 6;167(3):237-240. (Pubitemid 34920557)
71. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DEC. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002 Dec 21;360(9350):2047-2048. (Pubitemid 36026586)
72. Mosley BS, Cleves MA, Siega-Riz AM, Shaw GM, Canfield MA, Waller DK, et al. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 2009 Jan 1;169(1):9-17.
73. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005 Sep;116(3):580-586. (Pubitemid 44336670)
74. Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas-Mexico border: 1993-1995. Am J Epidemiol 1999 Jun 15;149(12):1119-1127. (Pubitemid 29270325)
75. Missmer SA, Suarez L, Felkner M, Wang E, Merrill AH, Rothman KJ, et al. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect 2006 Feb;114(2):237-241. (Pubitemid 43193645)
76. Harris JA, Shaw GM. Neural tube defects: Why are rates high among populations of Mexican descent? Environ Health Perspect 1995 Sep; 103(Suppl 6):163-164.
77. Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/Harris County, Texas: I. Descriptive Epidemiology Am J Epidemiol 1996 Jan 1;143(1):1-11.
78. Botto LD, Yang Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE Review. Am J Epidemiol 2000 May 1;151(9):862-877. (Pubitemid 30461127)
79. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Redlund M, et al. Geographical and ethnic variation of the 677C>T allele of 5, 10-methylenetetrahydrofolate reductase (Mthfr): Findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003 Aug 1;40(8):619-625. (Pubitemid 37046918)
80. Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. Mol Genet Metab 2000 May;70(1):45-52. (Pubitemid 30396203)
81. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 2004 Apr 1;41(4):256-260. (Pubitemid 38496767)
82. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (a80G), and risk of spina bifida. Am J Med Genet 2002 Feb 15;108(1):1-6. (Pubitemid 34101374)
83. Doolin M, Barbaux S, McDonnell M, Hoess K, Whitehead AS, Mitchell LE. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Human Genet 2002 Nov;71(5):1222-1226. (Pubitemid 35305242)
84. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, et al. The "Thermolabile" Variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Human Genet 1999 Apr;64(4):1045-1055. (Pubitemid 30463035)
85. Siega-Riz AM, Popkin BM, Carson T. Differences in food patterns at breakfast by sociodemographic characteristics among a nationally representative sample of adults in the United States. Prev Med 2000 May;30(5):415-424. (Pubitemid 30252828)
86. Hamner HC, Mulinare J, Cogswell ME, Flores AL, Boyle CA, Prue CE, et al. Predicted contribution of folic acid fortification of corn masa flour to the usual folic acid intake for the Us population: National Health and Nutrition Examination Survey 2001-2004. Am J Clin Nutr 2009 Jan;89(1):305-315.
87. Chen LT, Rivera MA. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev 2004 Jun;62(6 Pt 2):S40-43. (Pubitemid 38916079)
88. Martínez de Villarreal L, Pérez JZV, Vázquez PA, Herrera RH, Campos MDRV, et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México. Teratol 2002 Nov; 66(5):249-256. (Pubitemid 35266241)
89. Peller AJ, Westgate M, Holmes LB. Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination. Obstet Gynecol 2004 Nov;104(5 Pt 1):957-964. (Pubitemid 40458757)
90. Smith AD, Kim Y, Refsum H. Is folic acid good for everyone. Am J Clin Nutr 2008 Mar;87(3):517-533.
91. McNulty H, Pentieva K. Folate bioavailability. Proc Nutr Soc 2004 Nov;63(4):529-536. (Pubitemid 40558048)
92. Institute of Medicine. Washington, DC: National Academy Press; 2000. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin b6, folate, vitamin b12, pantothenic acid, biotin, and choline: a report of the standing committee on the scientific evaluation of dietary reference intakes and its panel on folate, other b vitamins, and choline and subcommittee on upper reference levels of nutrients; p. 357-373.
93. Fowles ER. What's a Pregnant Woman to Eat? a review of current Usda Dietary guidelines and My Pyramid. J Perinat Educ 2006;15(4):28-33.
94. Siega-Riz AM, Bodnar LM, Savitz DA. What are pregnant women eating? Nutrient and food group differences by race. Am J Obstet Gynecol 2002 Mar;186(3):480-486. (Pubitemid 34234161)
95. Inskip HM, Crozier SR, Godfrey KM, Borland SE, Cooper C, Robinson SM. Women's compliance with nutrition and lifestyle recommendations before pregnancy: General population cohort study. BMJ 2009:338b481.
96. Prue CE, Flores AL, Panissidi P, Lira A. But I've already had a healthy baby: Folic acid formative research with Latina mothers. J Womens Health (Larchmt) 2008 Oct;17(8):1257-1269.
97. Dheen ST, Tay SSW, Boran J, Ting LW, Kumar SD, Fu J, et al. Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview. Curr Med Chem 2009;16(18):2345-2354.
98. Shaw GM, Quach T, Nelson V, Carmichael SL, Schaffer DM, Selvin S, et al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr 2003 Nov;78(5):972-978. (Pubitemid 39663474)
99. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a meta analysis. Am J Obstet Gynecol 2008 Jun;198(6):611-619. (Pubitemid 351758926)
100. Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. Med Gen Med 2006;8(4):59.
101. Suarez L, Hendricks K, Felkner M, Gunter E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol 2003 Feb;13(2):81-88. (Pubitemid 36143706)
102. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, Scott JM, Mills JL. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics 2009 Mar;123(3):917-923.
103. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong P, et al. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiol 2007 May;18(3):362-366. (Pubitemid 46624947)
104. Finglas PM, de Meer K, Molloy A, Verhoef P, Pietrzik K, Powers HJ, et al. Research goals for folate and related B vitamin in Europe. Eur J Clin Nutr 2006 Feb;60(2):287-294.
105. Refsum H, Smith AD. Are we ready for mandatory fortification with vitamin B-12. Am J Clin Nutr 2008 Aug;88(2):253-254.
106. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiol 2005 Mar;16(2):216-219. (Pubitemid 40314414)
107. Felkner M, Hendricks K, Suarez L, Waller DK. Diarrhea: a new risk factor for neural tube defects? Birth Defects Research Part A: Clin Mol Teratol 2003 Jul;67(7):504-508. (Pubitemid 37238038)
108. Luben TJ, Messer LC, Mendola P, Carozza SE, Horel SA, Langlois PH. Urban-rural residence and the occurrence of neural tube defects in Texas, 1999-2003. Health Place 2009 Sep;15(3):848-854.
109. Kuehn CM, Mueller BA, Checkoway H, Williams M. Risk of malformations associated with residential proximity to hazardous waste sites in Washington state. Environ Res 2007 Mar;103(3):405-412. (Pubitemid 46217202)
110. Suarez L, Felkner M, Brender JD, Canfield M, Hendricks K. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J 2008 May;12(3):394-401. (Pubitemid 351513358)
111. U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. preventive services task force recommendation statement. Ann Intern Med 2009 May 5;150(9):626-631.
112. Gardiner PM, Nelson L, Shellhaas CS, Dunlop AL, Long R, Andrist S, Jack BW. The clinical content of preconception care: Nutrition and dietary supplements. Am J Obstet Gynecol 2008 Dec;199(6 Suppl 2):S345-356.
113. Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 2004 May;111(5):399-408. (Pubitemid 38621868)
114. Sharp, G.; Naylor, L.; Cai, J.; Hyder, M.; Chandra, P.; Guillory, V. Assessing awareness, knowledge and use of folic acid in Kansas women between the ages of 18 and 44 years [Internet]. Matern Child Health J. 2008 Sep 23. [cited 2009 Aug 17] Available from: http://www.ncbi.nlm.nih.gov/pubmed/18810617
115. Goldberg BB, Alvarado S, Chavez C, Chen BH, Dick LM, Felix RJ, et al. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: Survey results from a Teratogen Information Service. Birth Defects Research Part A: Clin Mol Teratol 2006 Mar;76(3):193-199.
116. Williams JL, Abelman SM, Fassett EM, Stone CE, Petrini JR, Damus K, et al. Health care provider knowledge and practices regarding folic acid, United States, 2002-2003. Matern Child Health J 2006 Sep;10(5 Suppl):S67-72.
117. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 2004 Mar;58(3):548-554. (Pubitemid 38443716)
118. Hubner RA, Houlston RS. Folate and colorectal cancer prevention. Br J Cancer 2009 Jan 27;100(2):233-239.
119. Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol 2009 Apr;21(4):436-439.
120. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007 Jul;16(7):1325-1329.
121. Mason JB. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev 2009 Apr;67(4):206-212.
122. Luebeck EG, Moolgavkar SH, Liu AY, Boynton A, Ulrich CM. Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev 2008 Jun;17(6):1360-1367.
123. Bollheimer LC, Buettner R, Kullmann A, Kullmann F. Folate and its preventive potential in colorectal carcinogenesis. How strong is the biological and epidemiological evidence? Crit Rev Oncol Hematol 2005 Jul;55(1):13-36. (Pubitemid 40779472)
124. Solomons NW. Food fortification with folic acid: Has the other shoe dropped? Nutrition Reviews 2007;65(11):512-515. (Pubitemid 351804343)
125. Kim Y. Folate: a magic bullet or a double-edged sword for colorectal cancer prevention? Gut 2006 Oct;55(10):1387-1389. (Pubitemid 44476778)
126. Larsson SC, Bergkvist L, Wolk A. Folate intake and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Epidemiol Biomarkers Prev 2008 Dec;17(12):3444-3449.
127. Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 2009 Feb;89(2):624-633.
128. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, et al. Folic acid and risk of prostate cancer: Results from a randomized clinical trial. J Natl Cancer Inst 2009 Mar 18;101(6):432-435.
129. French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003 Sep;74(3):288-294. (Pubitemid 37083104)
130. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998 Feb 4;279(5):359-364. (Pubitemid 28133864)
131. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997 Jul 24;337(4):230-237.
132. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006 Dec 13;296(22):2720-2726. (Pubitemid 44917549)
133. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008 May 7;299(17):2027-2036. (Pubitemid 351656584)
134. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther 2007 May;81(5):685-691. (Pubitemid 46625103)
135. Cotter AM, Daly SF. Neural tube defects: is a decreasing prevalence associated with a decrease in severity? Eur J Obstet Gynecol Reprod Biol 2005 Apr 1;119(2):161-163. (Pubitemid 40460374)
136. Leeming R, Lucock M. Autism: Is there a folate connection. J Inherited Metabolic Disease 2009 Jun 1;32(3):400-402.
137. Rogers EJ. Has enhanced folate status during pregnancy altered natural selection and possibly autism prevalence? a closer look at a possible link. Med Hypotheses 2008 Sep;71(3):406-410.
138. Ownby DR. Has mandatory folic acid supplementation of foods increased the risk of asthma and allergic disease? J Allergy Clin Immunol 2009 Jun;123(6):1260-1261.
139. Håberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009 Mar;94(3):180-184.
140. Hollingsworth JW, Maruoka S, Boon K, Garantziotis S, Li Z, Tomfohr J, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008 Oct;118(10):3462-3469.
141. Smith J, Empson M, Wall C. Recurrent anaphylaxis to synthetic folic acid. Lancet 2007;370:652. (Pubitemid 47299250)
142. Hirsch S, Sanchez H, Albala C, Maza MP de la, Barrera G, Leiva L, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol 2009;4:436-439.
143. Bower C, Milne E. Colon cancer in Chile. Eur J Gastroenterol Hepatol 2010;7:900.
144. Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland M, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009;302:2119-2126.
145. Safarinejad MR, Safarinejad SS. Efficacy of selenium and/or n-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol 2009;181(2):741-751.